...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith AGM

The business sense of these bufoons is that DM and the directors spun off the only real asset they had in hind sight. At least the asset which big pharma is interested in,,,,Management cant do anything with 208 but to make small talk about the possible future which we know is now actually behind us,,,,,just the team dont know it,,or at least tell us they dont!!

Only hope with these dogs is that WE get lucky and one of the big boys takes Zenith out,,,,and as noted early I am betting RVX will be tossed in as speculative colateral. 

Just an opnion from watching the effects of our management team still working from home.

Share
New Message
Please login to post a reply